Overview

Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the Effect of Puerarin tablets versus statins in treating metabolism syndrome in patients with chronic rheumatic diseases
Phase:
N/A
Details
Lead Sponsor:
Chengdu PLA General Hospital
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Atorvastatin
Atorvastatin Calcium
Protective Agents
Puerarin